Use of Long-acting Bupivacaine In Lower Extremity Amputation
Use of Liposomal Bupivacaine (Exparel) In Expedited Recovery Following Lower Extremity Amputation
Sponsor: Loma Linda University
Terminated
PI left institution
Other terminated trials from Loma Linda University
Other Amputation trials with similar outcome
Listed as NCT04360421, this PHASE4 trial focuses on Amputation and Anesthesia, Local and remains terminated or withdrawn. Sponsored by Loma Linda University, it has been updated 7 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Sep 2023 — Jul 2024 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Jun 2022 — Sep 2023 [monthly]
Recruiting PHASE4
-
Sep 2021 — Jun 2022 [monthly]
Recruiting PHASE4
▶ Show 2 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE4
-
May 2020 — Jan 2021 [monthly]
Recruiting PHASE4
First recorded
Apr 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Loma Linda University
For direct contact, visit the study record on ClinicalTrials.gov .